Detailed answers about SUSSEX HEALTH CLINICAL ADVISORY SERVICES LIMITED, including incorporation, status, business activity, and accounts information.
When was SUSSEX HEALTH CLINICAL ADVISORY SERVICES LIMITED founded?
SUSSEX HEALTH CLINICAL ADVISORY SERVICES LIMITED was officially incorporated on 10 February 2026 and is registered under company number 17023517. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is SUSSEX HEALTH CLINICAL ADVISORY SERVICES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of SUSSEX HEALTH CLINICAL ADVISORY SERVICES LIMITED?
SUSSEX HEALTH CLINICAL ADVISORY SERVICES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does SUSSEX HEALTH CLINICAL ADVISORY SERVICES LIMITED do?
SUSSEX HEALTH CLINICAL ADVISORY SERVICES LIMITED operates in the following sector: 21200 - Manufacture of pharmaceutical preparations. This provides insight into the company's primary business activity and industry focus.
What is SUSSEX HEALTH CLINICAL ADVISORY SERVICES LIMITED's registered address?
The registered office address of SUSSEX HEALTH CLINICAL ADVISORY SERVICES LIMITED is 93 FIRLE ROAD, SEAFORD, ENGLAND, BN25 2JA. This is the official address filed with Companies House for legal and statutory correspondence.
Is SUSSEX HEALTH CLINICAL ADVISORY SERVICES LIMITED financially stable?
Financial accounts for SUSSEX HEALTH CLINICAL ADVISORY SERVICES LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.